ScreenerHero

ACB Aurora Cannabis Inc.

NYSE · US · Healthcare · Drug Manufacturers - Specialty & Generic · auroramj.com
4.625USD+14.76%Mkt Cap: 255.14M $P/E: —

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and m…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap255.14M USD
Enterprise Value220.37M USD
Revenue (TTM)314.07M USD
Gross Profit136.65M USD
Net Income (TTM)-135.96M USD
Revenue/Share5.41 USD
Last Price4.625 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees1.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA05156X8843
Valuation
P/E (Trailing)—
P/E (Forward)-41.73
PEG—
EV/EBITDA-7.36
EV/Revenue0.70
P/S0.93
P/B0.79
EPS (TTM)-0.61
EPS (Forward)-0.11
52W Range
2.56050% of range6.665
52W High6.665 USD
52W Low2.560 USD
Profitability
Gross Margin42.62%
Oper. Margin-12.92%
EBITDA Margin-9.54%
Profit Margin-42.41%
ROE-26.56%
ROA-22.62%
Growth
Revenue Growth-8.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.51M USD
CapEx (TTM)22.55M USD
FCF Margin-6.38%
FCF Yield-7.85%
Net Debt-77.34M USD
Net Debt/EBITDA2.58
Balance Sheet
Debt/Equity0.05
Current Ratio5.36
Quick Ratio1.92
Book Value/Sh5.84 USD
Cash/Share1.54 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMay 11, 2020
Splits
Last Split1:10
Split DateFeb 20, 2024
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.63.31M
Float64.46M
Insiders1.21%
Institutions9.36%
Short Interest
Short Ratio6.6d
Short % Out.11.76%
Shares Short7.45M
Short (prev mo.)7.28M
Technical
SMA 503.687 (+25.4%)
SMA 2003.574 (+29.4%)
Beta1.42
S&P 52W Chg15.78%
Avg Vol (30d)1.45M
Avg Vol (10d)1.24M
Technical Indicators
RSI (14)66.5
MACD0.1072
MACD Signal0.1378
MACD Hist.-0.0306
BB Upper4.124 USD
BB Middle3.918 USD
BB Lower3.713 USD
BB Width10.50%
ATR (14)0.1355 USD
Vol Ratio (20d)0.81x